Abstract
Introduction: Community pharmacists are one of the most frequently accessed health professionals who can be involved in the provision of ongoing asthma management within the primary care setting. The aim of this study was to identify patients’ views regarding current asthma care provided by their pharmacists and their perspectives on future pharmacy-based asthma services.
Methods: This is a qualitative approach with an interview guide. Asthma patients were purposively selected. Interviews were conducted from April to June 2017. Patient’s opinions about asthma and its management and their experiences regarding asthma care provided by pharmacists were collected. Data were analyzed using content analysis.
Results: Thirty-three interviews were conducted. Asthma literacy was low. There was dis-engagement with the health care system, with only a few participants trusting conventional health care professionals. Alternative medicine systems and practitioners were better trusted and participants had strong preferences for family/peer involvement in their asthma care. Participants also had misunderstandings regarding their asthma disease and medications. Participants had experienced little pharmaceutical care provided by pharmacists but would welcome it in the future.
Conclusion: Given the accessibility of community pharmacy venues and readiness of the profession for more involved care of chronic disease patients, it may be recommended that Indonesian community pharmacists should adopt the provision of pharmaceutical care models for asthma. Such pharmaceutical care models need to incorporate patients’ unique sociocultural health beliefs, preferences for alternative medicines and family/social peer involvement as well as stronger collaboration between pharmacists and physicians.
Keywords:
Acknowledgements
The authors would like to thank the Indonesian Ministry of Research, Technology and Higher Education (Kemenristekdikti) for the research grant through Hibah Penelitian Fundamental Kerja Sama Luar Negeri (PKLN) scheme in 2017–2019 (No. 109/SP2H/LT/DPRM/2018 and No. 017/Penel. LPPM USD/III/2018), also to all the research assistants, and the asthma patients for their contribution and participation in this study.
Disclosure of interest
No conflict of interest